Ligand id: 8254

Name: ozanezumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9703 ozanezumab
GSK-1223249 | GSK1223249
Ozanezumab is a humanised mouse monoclonal antibody targeting NOGO-A (reticulon-4, RTN4). This antibody is in GlaxoSmithKline's development pipeline of drugs for rare diseases, in this case amyotrophic lateral sclerosis (ALS aka motor neurone disease or MND) and was also investigated for multiple sclerosis (MS).
Although peptide sequences for ozanezumab are available, a BLAST search provided no exact matches with patented protein sequences
Database Links
Specialist databases
IMGT/mAb-DB 454
Other databases
GtoPdb PubChem SID 249565934
Search PubMed clinical trials ozanezumab
Search PubMed titles ozanezumab
Search PubMed titles/abstracts ozanezumab
Wikipedia Ozanezumab